Despite advances in treatment and clear guidelines, many patients with diabetes are failing to achieve target glucose levels. One of the main challenges posing a barrier to improved outcomes is clinical and therapeutic inertia, where providers and patients with diabetes do not initiate or intensify treatment regimens despite it being appropriate. This is often the case with insulin regimes. Insulin therapy has been proven to significantly reduce hemoglobin A1c levels and better manage hyperglycemia, yet countless studies show that insulin initiation and intensification is frequently and inappropriately delayed.

During this webinar, Amy Butts, PA-C, MPAS, CDE, BC-ADM, an Endocrine Physician Assistant with Wheeling Hospital and Dr. Mark Vanderwel, Medical Director of the Pediatric Endocrinology Division at Atrium Health, will discuss the current challenges in initiating and managing insulin therapy, review the standards of care for both the inpatient and outpatient setting, and discuss how technology can be used and implemented to benefit both patients and providers.

 

At the end of this webinar, attendees will be able to:

 

Speakers

Amy Butts PA-C, MPAS, CDE, BC-ADM
Endocrine Physician Assistant, Wheeling Hospital

Mark Vanderwel, MD
Medical Director of the Pediatric Endocrinology Division, Atrium Health

 

Who Should Attend: Healthcare professionals involved in glycemic management, including Physicians, Endocrinologists, Medication Safety Officers, Pharmacy Directors, Chief Medical Officers, Chief Nursing Officers, Chief Quality Officers, Heads of Diabetes or Glycemic Care, and Certified Diabetes Educators.

 

Register for the Webinar